These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25762321)

  • 21. Characterization of hyperactive mutations in the renal potassium channel ROMK uncovers unique effects on channel biogenesis and ion conductance.
    Nguyen NH; Sheng S; Banerjee A; Guerriero CJ; Chen J; Wang X; Mackie TD; Welling PA; Kleyman TR; Bahar I; Carlson AE; Brodsky JL
    Mol Biol Cell; 2024 Sep; 35(9):ar119. PubMed ID: 39024255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complementary computational and experimental evaluation of missense variants in the ROMK potassium channel.
    Ponzoni L; Nguyen NH; Bahar I; Brodsky JL
    PLoS Comput Biol; 2020 Apr; 16(4):e1007749. PubMed ID: 32251469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome mining yields putative disease-associated ROMK variants with distinct defects.
    Nguyen NH; Sarangi S; McChesney EM; Sheng S; Durrant JD; Porter AW; Kleyman TR; Pitluk ZW; Brodsky JL
    PLoS Genet; 2023 Nov; 19(11):e1011051. PubMed ID: 37956218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the inward-rectifier potassium channel ROMK in cardiovascular disease.
    Garcia ML; Kaczorowski GJ
    Curr Opin Pharmacol; 2014 Apr; 15():1-6. PubMed ID: 24721647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.
    Tang H; Walsh SP; Yan Y; de Jesus RK; Shahripour A; Teumelsan N; Zhu Y; Ha S; Owens KA; Thomas-Fowlkes BS; Felix JP; Liu J; Kohler M; Priest BT; Bailey T; Brochu R; Alonso-Galicia M; Kaczorowski GJ; Roy S; Yang L; Mills SG; Garcia ML; Pasternak A
    ACS Med Chem Lett; 2012 May; 3(5):367-72. PubMed ID: 24900480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of Golgin-160 in cell surface transport of renal ROMK channel: co-expression of Golgin-160 increases ROMK currents.
    Bundis F; Neagoe I; Schwappach B; Steinmeyer K
    Cell Physiol Biochem; 2006; 17(1-2):1-12. PubMed ID: 16543716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1.
    Lewis LM; Bhave G; Chauder BA; Banerjee S; Lornsen KA; Redha R; Fallen K; Lindsley CW; Weaver CD; Denton JS
    Mol Pharmacol; 2009 Nov; 76(5):1094-103. PubMed ID: 19706730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Kir channels by intracellular pH and extracellular K(+): mechanisms of coupling.
    Dahlmann A; Li M; Gao Z; McGarrigle D; Sackin H; Palmer LG
    J Gen Physiol; 2004 Apr; 123(4):441-54. PubMed ID: 15051808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Renal Outer Medullary Potassium Channel (ROMK): An Intriguing Pharmacological Target for an Innovative Class of Diuretic Drugs.
    Calderone V; Martelli A; Piragine E; Citi V; Testai L; Breschi MC
    Curr Med Chem; 2018; 25(23):2627-2636. PubMed ID: 29022503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROMK is required for expression of the 70-pS K channel in the thick ascending limb.
    Lu M; Wang T; Yan Q; Wang W; Giebisch G; Hebert SC
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F490-5. PubMed ID: 14600033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet.
    Bailey MA; Cantone A; Yan Q; MacGregor GG; Leng Q; Amorim JB; Wang T; Hebert SC; Giebisch G; Malnic G
    Kidney Int; 2006 Jul; 70(1):51-9. PubMed ID: 16710355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subunit-subunit interactions are critical for proton sensitivity of ROMK: evidence in support of an intermolecular gating mechanism.
    Leng Q; MacGregor GG; Dong K; Giebisch G; Hebert SC
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1982-7. PubMed ID: 16446432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic potential of targeting the K
    Priest BT; Pasternak A
    Future Med Chem; 2017 Oct; 9(16):1963-1977. PubMed ID: 29076349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/Natriuretic.
    Jiang J; Ding FX; Zhou X; Bateman TJ; Dong S; Gu X; Keh deJesus R; Pio B; Tang H; Chobanian HR; Levorse D; Hu M; Thomas-Fowlkes B; Margulis M; Koehler M; Weinglass A; Gibson J; Houle K; Yudkovitz J; Hampton C; Pai LY; Samuel K; Cutarelli T; Sullivan K; Parmee ER; Davies I; Pasternak A
    J Med Chem; 2021 Jun; 64(11):7691-7701. PubMed ID: 34038119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energetics and location of phosphoinositide binding in human Kir2.1 channels.
    D'Avanzo N; Lee SJ; Cheng WWL; Nichols CG
    J Biol Chem; 2013 Jun; 288(23):16726-16737. PubMed ID: 23564459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
    Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
    J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule.
    Takemoto Y; Slough DP; Meinke G; Katnik C; Graziano ZA; Chidipi B; Reiser M; Alhadidy MM; Ramirez R; Salvador-Montañés O; Ennis S; Guerrero-Serna G; Haburcak M; Diehl C; Cuevas J; Jalife J; Bohm A; Lin YS; Noujaim SF
    FASEB J; 2018 Apr; 32(4):1778-1793. PubMed ID: 29162702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Peters M; Ermert S; Jeck N; Derst C; Pechmann U; Weber S; Schlingmann KP; Seyberth HW; Waldegger S; Konrad M
    Kidney Int; 2003 Sep; 64(3):923-32. PubMed ID: 12911542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive guide to the ROMK potassium channel: form and function in health and disease.
    Welling PA; Ho K
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F849-63. PubMed ID: 19458126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mineralocorticoid and K+ concentration on K+ secretion and ROMK channel expression in a mouse cortical collecting duct cell line.
    Fodstad H; Gonzalez-Rodriguez E; Bron S; Gaeggeler H; Guisan B; Rossier BC; Horisberger JD
    Am J Physiol Renal Physiol; 2009 May; 296(5):F966-75. PubMed ID: 19297448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.